Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in XGN — Exagen Inc.

CIK 1595888 NEW YORK, NY
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,499,633
+$789,428 QoQ
Shares Held
322,502
+36.2% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 57 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Derivatives in XGN

reported options exposure · as of Dec 31, 2025
CallValue
$92,416
CallShares
15,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $941,973,796 across 32 Diagnostics & Research names. XGN ranks #19 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 1,783,444 $267,570,103
2 NTRA
Natera, Inc.
 926,986 $251,630,349
3 ILMN
Illumina, Inc.
 372,628 $65,519,180
4 ICLR
Icon PLC
 374,800 $65,106,507
5 RVTY
Revvity, Inc.
 576,014 $64,087,317
6 IDXX
Idexx Laboratories Inc /De
 105,108 $55,333,055
7 IQV
Iqvia Holdings Inc.
 282,508 $54,586,195
8 DHR
Danaher Corp /De/
 189,123 $36,024,147

All Filings in XGN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,499,633 322,502
2026-03-31 $710,205 236,735
2025-12-31 $1,179,738 194,036
2025-12-31 $92,416 15,200
2025-09-30 $129,682 11,800
2025-09-30 $1,124,353 102,307